Source: MarketScreener

MusclePharm: MusclePharm : Late Filing Notice - Form NT 10-Q

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53166 ...https://www.marketscreener.com/quote/stock/MUSCLEPHARM-CORPORATION-120792970/news/MusclePharm-Late-Filing-Notice-Form-NT-10-Q-41340316/?utm_medium=RSS&utm_content=20220817

Read full article »
MusclePharm's Competitors | MusclePharm's News | MusclePharm's Financials
Stay up-to-date with the latest news on MusclePharm
Annual Revenue
$25-100M
Employees
1-25
Ryan Drexler's photo - Chairman & CEO of MusclePharm

Chairman & CEO

Ryan Drexler

CEO Approval Rating

87/100

Read more
Stay up-to-date with the latest news on MusclePharm